Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$892M |
| 2 |
Merck
MRK
|
+$858M |
| 3 |
Amgen
AMGN
|
+$857M |
| 4 |
Home Depot
HD
|
+$837M |
| 5 |
Cisco
CSCO
|
+$781M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$776M |
| 2 |
United Parcel Service
UPS
|
+$615M |
| 3 |
Qualcomm
QCOM
|
+$587M |
| 4 |
Alibaba
BABA
|
+$555M |
| 5 |
Eaton
ETN
|
+$508M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Financials | 12.96% |
| 3 | Healthcare | 11.88% |
| 4 | Consumer Discretionary | 11.22% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Cadiz
CDZI
$251M
| $542K | ﹤0.01% |
56,418
| – | – |
|
|
ELOX
3052
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
| $541K | ﹤0.01% |
4,070
| – | – |
|
|
SBT
3053
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $540K | ﹤0.01% |
95,377
+2,848
| +3% | +$14.8K |
|
3054
Bionano Genomics
BNGO
$12.3M
| $538K | ﹤0.01% |
+111
| New | +$626K |
|
3055
LCNB Corp
LCNB
$282M
| $538K | ﹤0.01% |
30,738
| – | – |
|
|
IIN
3056
DELISTED
IntriCon Corporation
IIN
| $537K | ﹤0.01% |
20,906
-1,637
| -7% | -$36.2K |
|
3057
Global Water Resources
GWRS
$206M
| $536K | ﹤0.01% |
32,807
+1,777
| +6% | +$29.9K |
|
3058
BCB Bancorp
BCBP
$173M
| $535K | ﹤0.01% |
38,744
+5,214
| +16% | +$68.5K |
|
3059
Rimini Street
RMNI
$449M
| $533K | ﹤0.01% |
59,418
+12,662
| +27% | +$98K |
|
3060
Escalade
ESCA
$273M
| $532K | ﹤0.01% |
25,406
+27
| +0.1% | +$584 |
|
|
REV
3061
DELISTED
Revlon, Inc.
REV
| $531K | ﹤0.01% |
43,047
-1,653
| -4% | -$19.3K |
|
|
HBMD
3062
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $530K | ﹤0.01% |
32,234
-9,846
| -23% | -$141K |
|
|
AGTC
3063
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $528K | ﹤0.01% |
104,130
+35,648
| +52% | +$185K |
|
3064
Northeast Bank
NBN
$1.06B
| $525K | ﹤0.01% |
19,882
+2,590
| +15% | +$69.4K |
|
|
BELFB
3065
Bel Fuse Inc Class B
BELFB
$3.87B
| $524K | ﹤0.01% |
26,338
+2,337
| +10% | +$41.3K |
|
3066
Harvard Bioscience
HBIO
$27.5M
| $522K | ﹤0.01% |
9,549
+696
| +8% | +$33.9K |
|
|
RESN
3067
DELISTED
Resonant Inc.
RESN
| $517K | ﹤0.01% |
121,838
-9,835
| -7% | -$52.8K |
|
3068
First Bank
FRBA
$464M
| $514K | ﹤0.01% |
42,162
+2,933
| +7% | +$31.7K |
|
3069
Fulcrum Therapeutics
FULC
$273M
| $514K | ﹤0.01% |
43,630
+6,616
| +18% | +$81.8K |
|
3070
iShares S&P GSCI Commodity-Indexed Trust
GSG
$998M
| $512K | ﹤0.01% |
36,648
+23,115
| +171% | +$317K |
|
3071
Timberland Bancorp
TSBK
$348M
| $511K | ﹤0.01% |
18,368
| – | – |
|
|
HOOK
3072
DELISTED
HOOKIPA Pharma
HOOK
| $508K | ﹤0.01% |
3,774
+515
| +16% | +$62.1K |
|
3073
INNOVATE Corp
VATE
$111M
| $508K | ﹤0.01% |
12,883
-2,083
| -14% | -$77.3K |
|
|
SMED
3074
DELISTED
Sharps Compliance Corp
SMED
| $507K | ﹤0.01% |
35,240
-3,070
| -8% | -$39.5K |
|
3075
BayCom
BCML
$329M
| $505K | ﹤0.01% |
27,969
-385
| -1% | -$6.29K |
|
Similar funds
Charles Schwab's Q1 2021 Portfolio in Review
As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
- Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
- Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
- Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
- Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
- Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
- Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.
Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.